Effect Of Fluticasone Propionate/Salmeterol (250/50) On Arterial Stiffness In Patients With COPD

被引：0
|
作者：
Dransfield, M. T.
Cockcroft, J.
Townsend, R.
Coxson, H. O.
Sharma, S.
Rubin, D.
Emmett, A.
Cicale, M.
Crater, G.
Martinez, F. J.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2631
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD
    Maltais, Francois
    Mahler, Donald A.
    Pepin, Veronigue
    Nadreau, Eric
    Crater, Glenn D.
    Morris, Andrea N.
    Emmett, Amanda H.
    Ferro, Thomas J.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (02) : 539 - 541
  • [42] Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
    Soriano, JB
    Vestbo, J
    Pride, NB
    Kiri, V
    Maden, C
    Maier, WC
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (04) : 819 - 825
  • [43] Reflections on TORCH: Potential Mechanisms for the Survival Benefit of Salmeterol/Fluticasone Propionate in COPD Patients
    Johnson, M.
    Agusti, A. G. N.
    Barnes, N. C.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2008, 5 (06) : 369 - 375
  • [44] Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination
    Brown, Rachel A.
    Allegra, Luigi
    Matera, Maria G.
    Page, Clive P.
    Cazzola, Mario
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (06) : 419 - 424
  • [45] Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma
    Bergmann, KC
    Lindemann, L
    Braun, R
    Steinkamp, G
    SWISS MEDICAL WEEKLY, 2004, 134 (3-4) : 50 - 58
  • [46] The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD
    Herth, Felix
    Hohlfeld, Jens M.
    Haas, Johannes
    de la Hoz, Alberto
    Jin, Xidong
    Kreitner, Karl-Friedrich
    Vogelmeier, Claus
    Vogel-Claussen, Jens
    Watz, Henrik
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [47] Effect of fluticasone 250 μg/salmeterol 50 μg and montelukast on exhaled nitric oxide in asthmatic patients
    Gelb, Arthur F.
    Taylor, Colleen Flynn
    Shinar, Chris M.
    Gutierrez, Carlos A.
    Zamel, Noe
    CANADIAN RESPIRATORY JOURNAL, 2008, 15 (04) : 193 - 198
  • [48] Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial
    Singh, Dave
    Worsley, Sally
    Zhu, Chang-Qing
    Hardaker, Liz
    Church, Alison
    BMC PULMONARY MEDICINE, 2015, 15
  • [49] Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD
    Hanania, Nicola A.
    Crater, Glenn D.
    Morris, Andrea N.
    Emmett, Amanda H.
    O'Dell, Dianne M.
    Niewoehner, Dennis E.
    RESPIRATORY MEDICINE, 2012, 106 (01) : 91 - 101
  • [50] Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial
    Dave Singh
    Sally Worsley
    Chang-Qing Zhu
    Liz Hardaker
    Alison Church
    BMC Pulmonary Medicine, 15
12345